2011/09/27 12:00 - Asian Activities Report for September 27, 2011 includes: General Mining Corporation Limited (ASX:GMM) has signed an agreement to acquire a coal exploration licence in Mongolia; Aphrodite Gold Limited (ASX:AQQ) announced further robust gold intersections at its Aphrodite Gold Deposit; Agenix Limited (ASX:AGX) has filed a patent application for its hepatitis B drug AGX-1009; Manas Resources Limited (ASX:MSR) reported a 20% increase in its Shambesai Total Mineral Resource to 766,000 ounces of gold; Infotech Enterprises Limited (BOM:532175) announced its partnership with Software Engineering Institute.
2011/09/27 08:27 - Global regenerative medicine company Mesoblast Limited (ASX:MSB) and Lonza Group (VTX:LONN), a world leader in biologic manufacturing, today announced that they have entered into a strategic alliance for clinical and long-term commercial production of Mesoblast's off-the-shelf (allogeneic) adult stem cell products.
2011/09/09 14:16 - ADX Energy Ltd (ASX:ADX) is pleased to announce a Sale and Purchase Agreement has been executed to buy back a further 10% interest in the Lambouka Prospect Area in the Kerkouane Permit from PharmAust Limited (ASX:PAA) and to cancel the option of PAA to purchase an interest in that part of the Lambouka prospect that extends into Italian waters.
2011/09/09 12:00 - Asian Activities Report for September 9, 2011 includes: HealthLinx Limited (ASX:HTX) is to begin a 350 patient academic study as the first step to launch the OvPlex(TM) ovarian cancer diagnostic in China; Amex Resources Limited (ASX:AXZ) today provided an update on the Company's recent advancements on the MBa Delta Ironsands Project in Fiji; Orocobre Limited (ASX:ORE) has received approval to drill exploratory wells on its Cauchari Project in Argentina; Coalbank Limited (ASX:CBQ) has engaged an independent technical expert to review its metals projects portfolio.
2011/09/07 12:02 - Asian Activities Report for September 7, 2011 includes: AnaeCo Limited (ASX:ANQ) has formed a joint venture company for the deployment of the DiCOM(TM) System in Asia; Integra Mining Limited (ASX:IGR) says today that the first month of production following the Randalls Gold Project processing facility upgrade has exceeded expectations; Krucible Metals Limited (ASX:KRB) has received drilling results at the Korella Phosphate and Rare Earth Project in Queensland; ZYL Limited (ASX:ZYL) announced the interim results of the Bankable Feasibility Study at the Kangwane Anthracite Project; Suven Life Sciences Limited (BOM:530239) announces the grant of four product patents from Australia and New Zealand.
2011/09/05 08:36 - Global regenerative medicine company, Mesoblast Limited (ASX:MSB), today announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascor(TM) in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack. Revascor(TM) is an allogeneic, or "off-the-shelf", adult stem cell product derived from Mesoblast's proprietary Mesenchymal Precursor Cell (MPC) platform technology which is being developed for use in a range of cardiovascular diseases including congestive heart failure, chronic angina, and heart attacks.
2011/09/01 12:00 - Asian Activities Report for September 1, 2011 includes: CBD Energy (ASX:CBD) has signed an agreement to participate in the management of the AusChina Energy Joint Venture; TVN Corporation Pty Ltd (ASX:TVN) announced the results from its latest drilling on the Nuurst Project in Mongolia; Uran Limited (ASX:URA) has commenced commercial open pit mining activities at the Emmanuel Project in Zambia; Aviva Corporation Limited (ASX:AVA) has recently completed a maiden resource estimate on the Bumbo Base Metal Deposit in West Kenya; Manas Resources Limited (ASX:MSR) has completed a 12,500 metre drilling program at Shambesai Gold Project in the Kyrgyz Republic; Daiichi Sankyo Company, Limited (TYO:4568) and Ranbaxy Laboratories Limited (BOM:500359) today announced a joint initiative to sponsor mobile healthcare clinics in India, Cameroon and Tanzania.
2011/08/24 12:00 - Asian Activities Report for August 24, 2011 includes: TVN Corporation Pty Ltd (ASX:TVN) announced the results from its latest drilling activities at the Nuurst Project in Mongolia; PMI Gold Corporation (ASX:PVM) reported further positive drilling results from its 100%-owned Obotan Gold Project in Ghana; Senex Energy Limited (ASX:SXY) secures agreement for the pipeline transportation of crude oil from Snatcher oil field; Australia Minerals and Mining Group Limited (ASX:AKA) has updated its kaolin resource at Yilgarn project areas in Western Australia; Biocon Limited's (BOM:532523) subsidiary Clinigene International Limited has signed a strategic partnership agreement with Spaulding Clinical Research, LLC.
2011/08/24 10:00 - Regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY), today provided its full year financial results. The company stated that it had substantial funds of A$263.2 million at 30 June 2011. Mesoblast recorded revenue and other income of A$120.9 million and a profit before tax of A$92.2 million.
2011/08/22 08:32 - Regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY), today announced that the first minimally-invasive lumbar disc procedure had been successfully performed in the Phase 2 clinical trial of its proprietary adult Mesenchymal Precursor Cell product for the treatment of low back pain and degenerative disc disease. The outpatient procedure lasted less than 20 minutes, with the patient fully awake and under light sedation. The patient was shortly discharged and there were no complications.
2011/08/19 12:00 - Asian Activities Report for August 19, 2011 includes: SmartTrans Holdings Limited (ASX:SMA) has signed a binding agreement with China Mobile (HKG:0941) (NYSE:CHL) that allows SmartTrans to collect payment from China Mobile customers; Golden Rim Resources Limited (ASX:GMR) today announced copper and gold intersections from the second program of reverse circulation drilling at its Balogo Project in Burkina Faso; Highlands Pacific Limited (ASX:HIG) said today that its fully constructed US$1.5 billion Ramu Nickel project in Papua New Guinea will commence ore commissioning activities at the Basamuk treatment plant in September; Aquila Resources Limited (ASX:AQA) said today that the Queensland Government has granted the Mining Lease for the Eagle Downs Hard Coking Coal Project in Central Queensland; Suven Life Sciences Limited (BOM:530239) has been granted 4 product patents for the treatment of Neurodegenerative disorders.
2011/08/15 09:40 - Global regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY), today announced that its heart failure clinical trial has been chosen by the American Heart Association to be featured at its 2011 annual conference in Orlando, Florida, in the "Clinical Science: Special Reports" session on November 14. More than 17,000 international cardiovascular specialists are expected to attend the conference.
2011/08/12 12:00 - Asian Activities Report for August 12, 2011 includes: Newly ASX-listed rare earths company Strategic Elements Limited (ASX:SOR) has expanded its search for rare earths and rare metals to Ireland; Dragon Mining Limited (ASX:DRA) has received the first results from the drilling campaign on the Hangaslampi gold deposit in northern Finland; Canyon Resources Limited (ASX:CAY) has entered into an agreement to purchase the Wilier Project in eastern Burkina Faso; Whinnen Resources Limited (ASX:WWW) has commenced its maiden drilling program at the Nany-Varas gold project in Northern Chile; Piramal Healthcare (BOM:500302) and Vodafone Group (LON:VOD) announced that Piramal has agreed to purchase approximately 5.5% of the issued equity share capital of Vodafone Essar Limited.
2011/08/02 12:00 - Asian Activities Report for August 2, 2011 includes: Astro Resources NL (ASX:ARO) has secured the rights to acquire the majority share in the Scott Coastal Plain Mineral Sands Project in Western Australia; Nexbis Limited (ASX:NBS) has signed a 12-year agreement for its Malaysian project; Gullewa Limited (ASX:GUL) reported a three-metre thick coal seam at Back Creek in Queensland; China Magnesium Corporation Limited's (ASX:CMC) first phase expansion of the Pingyao Magnesium Project is progressing as expected and on schedule; Claris Lifesciences Limited (BOM:533288) received approvals to re-launch its Bag Products in the European Union.
2011/07/29 12:00 - Asian Activities Report for July 29, 2011 includes: Northern Minerals Limited (ASX:NTU) announced exciting Heavy Rare Earth Element results from the Browns Range Project in northern Western Australia; Scandinavian Resources Limited (ASX:SCR) has updated global JORC compliant mineral resource for the Kiruna Iron Project in northern Sweden; Venture Minerals Limited (ASX:VMS) announced a maiden direct shipping ore resource of 2.2 million tonnes at 58% Fe at the newly defined Livingstone Deposit; Australia China Holdings Limited (ASX:AAK) has signed a Memorandum of Understanding with Denzo Group to form a Joint Venture Company in China; Dr. Reddy's Laboratories Limited (BOM:500124) has signed a Memorandum of Understanding with Fujifilm Corporation (TYO:4901) for an exclusive partnership in the Generic Drugs business for the Japanese market.
2011/07/28 12:02 - Asian Activities Report for July 28, 2011 includes: Novogen Limited's (ASX:NRT) subsidiary, Marshall Edwards, Inc.(NASDAQ:MSHL) announced the publication of results from a pre-clinical study of NV-128; Anatolia Energy Limited (ASX:AEK) announced an initial JORC Mineral Resource estimate for the Temrezli uranium prospect in Turkey; Waratah Resources Limited (ASX:WGO) has signed a binding Share Sale Agreement to acquire the Okanabora Project in the Republic of Congo; David Jones Limited (ASX:DJS) is launching a new brand campaign for Spring/Summer 2011.
2011/07/07 09:23 - Global regenerative medicine company Mesoblast Limited (ASX:MSB) (PINK:MBLTY), today announced that it has received clearance from the United States Food and Drug Administration to begin a Phase 3 clinical trial for bone marrow regeneration in patients with blood cancers. FDA clearance was obtained within the 30-day minimum time period after Mesoblast filed its Phase 3 Investigational New Drug submission.
2011/06/29 09:22 - Regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY), today announced that it has received clearance from the United States Food and Drug Administration to begin a Phase 2 clinical trial of its proprietary adult Mesenchymal Precursor Cell (MPC) product for the treatment of degenerative disc disease.
2011/06/14 12:26 - Global regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY), was featured today at the 8th Nomura Asia Equity Forum being held in Singapore. Mesoblast was the only Australian company to present at the respected Asian investor forum.
2011/06/09 09:39 - Results from Mesoblast Limited's (ASX:MSB) (PINK:MBLTY) cardiovascular clinical trials were featured at the Goldman Sachs 32nd Annual Global Healthcare Conference in California today.
2011/06/08 12:00 - Asian Activities Report for June 8, 2011 includes: Agenix (ASX:AGX) is on track to begin clinical trials in China for its lead Hepatitis B drug; Central Asia Resources Limited (ASX:CVR) reported gold resource increase to 124,000 ounces at Dalabai Gold Project; Tanami Gold NL (ASX:TAM) announced a further substantial increase in its gold Mineral Resources to 2.30 million ounces of gold; Corazon Mining Limited (ASX:CZN) confirmed the existence of a high-grade nickel/copper sulphide discovery at the Lynn Lake nickel sulphide project in Canada.
2011/06/06 10:19 - Global regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY), today announced that its Chief Executive, Silviu Itescu, will present at the Goldman Sachs (NYSE:GS) 32nd Annual Global Healthcare Conference in the United States. Mesoblast joins Resmed and Ramsay Healthcare as the only Australian companies participating in the global investor forum.
2011/05/24 16:26 - Providing a seamless, integrated system of care across a range of healthcare settings, accountable care organizations are increasingly being touted as the cure for a failing health system. But challenges remain.
2011/05/24 09:40 - Australian regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY), today announced that the company's product development strategy has been significantly strengthened by novel composition of matter claims granted by the United States Patent and Trade Mark Office in two distinct patent families to which Mesoblast has exclusive worldwide commercial rights.
2011/04/27 09:58 - Sino Gas & Energy Holdings Limited (ASX:SEH), an Australian company developing unconventional gas assets within the Ordos Basin, Shanxi Province China, is pleased to advise that it has signed an agreement to raise up to A$29.4 million in new funds from SpringTree Special Opportunities Fund, LP, a New York-based institutional investor, over the next two years.
2011/04/18 09:41 - Standard and Poor's Indices has announced that regenerative medicine company Mesoblast Limited (ASX:MSB) (PINK:MBLTY) will be included in the S&P/ASX 200 Index, effective after the close of business on Wednesday 27 April, 2011.
2011/04/11 08:52 - Benitec Limited (ASX:BLT) (PINK:BNIKF) is pleased to announce that it is undertaking a fully underwritten Renounceable Rights Issue to raise approximately $8 million, following an agreement reached with La Jolla Cove Investors Inc to terminate their convertible note funding arrangement with Benitec.
2011/04/07 09:19 - Mesoblast Limited (ASX:MSB) (PINK:MBLTY) wishes to inform the market that the Board of its strategic partner Cephalon Inc. (NASDAQ:CEPH) has rejected the unsolicited proposal from Valeant Pharmaceuticals International Inc (NYSE:VRX) to acquire its issued share capital or certain assets.
2011/04/06 12:00 - Asian Activities Report for April 6, 2011 includes: Motopia Limited's (ASX:MOT) subsidiary cBox Pty Ltd has been appointed as Business Wire's Australasian media distribution partner; MACA Limited (ASX:MLD) is to provide iron ore crushing and screening services for WPG Resources Limited (ASX:WPG); Rey Resources Limited (ASX:REY) announced an upgraded thermal coal Measured Resources at Duchess Paradise Project; Circadian Technologies Limited (ASX:CIR) said that VGX-100 significantly inhibits the growth and spread of various types of human tumour.
2011/04/04 08:36 - iSOFT Group Limited (ASX:ISF) announces it has entered into a Scheme Implementation Agreement with CSC Computer Sciences Australia Holdings Pty Ltd, a wholly owned subsidiary of Computer Sciences Corporation (NYSE:CSC) for the proposed acquisition by CSC of all the ordinary issued shares in iSOFT.
2011/03/31 17:50 - Mesoblast Limited (ASX:MSB) (PINK:MBLTY), has received a number of enquiries from shareholders and analysts regarding yesterday's announcement by Mesoblast's strategic partner Cephalon Inc. (NASDAQ:CEPH) that it had received an unsolicited proposal from Valeant Pharmaceuticals International Inc (TSE:VRX) to acquire Cephalon's issued share capital or certain assets. Mesoblast continues to maintain a close dialogue with Cephalon.
2011/03/31 16:06 - China Hospital Investment & Management Summit 2011 will be hosted by Duxes Business Consulting Inc. on July 7-8 in Beijing at the Swissôtel Beijing Hong Kong Macau Center. The 2011 Summit will provide a platform to discuss the policies and regulations effecting China's rapidly expanding hospital industry as a result of the recently issued Views on Further Encouraging and Guiding the Investment of Social Capital Toward Medical Institutions, focused on healthcare reform and hospital development.
2011/03/29 14:24 - Benitec Limited (ASX:BLT) (PINK:BNIKF) today welcomed the publication of research by scientists at the University of Queensland who demonstrated the value of Benitec's gene silencing platform technology to provide effective human therapeutics for cancer. Their results were published this month in the prestigious international scientific journal Cancer Gene Therapy.
2011/03/28 12:00 - Asian Activities Report for March 28, 2011 includes: Avonlea Minerals Limited (ASX:AVZ) said today that test results have confirmed high grade potential at Thresher, Hammerhead and Bronzy magnetite iron ore prospects in Namibia; Quickstep Holdings Limited (ASX:QHL) is participating in a European research project to investigate the use of nanotechnology to improve material properties; Alexium International Group Limited (ASX:AJX) has signed an agreement with International Textile Group (PINK:ITXN) to collaborate on product development; QRxPharma Limited (ASX:QRX) is on track to file FDA drug application for MoxDuo(R) IR in mid-2011.
2011/03/22 13:56 - Benitec Limited (ASX:BLT) (PINK:BNIKF), a world leader in expressed gene silencing for human therapeutics, today announced further positive progress in its fundamental Graham family patent applications exclusively licensed from CSIRO worldwide for human therapeutics. These patents cover silencing of genes using DNA-directed RNA interference (ddRNAi). Progress on these patent applications further strengthens Benitec's position with regards to both its revenue opportunities from licensing of ddRNAi technology for research use and in the commercialization potential of its ddRNAi-based therapeutics, being developed both in house and for the treatment of chronic and life threatening medical conditions, such as infectious diseases and cancer.
2011/03/21 10:59 - Benitec Limited (ASX:BLT) (PINK:BNIKF), a world leader in RNA-based gene silencing for human therapeutics, is pleased to acknowledge that the City of Hope research hospital in Duarte, California is planning to initiate a second small Phase I/II study using Benitec's DNA-directed RNA interference (ddRNAi) technology in lymphoma patients carrying the HIV virus. The aim of the study is to optimize the treatment by modifying a range of clinical parameters.
2011/03/17 09:43 - Regenerative medicine company Mesoblast Limited (ASX:MSB) (PINK:MBLTY) today announced that Chief Executive Officer Professor Silviu Itescu has been named BioSpectrum Asia Pacific Person of the Year 2011. BioSpectrum Asia is the leading Asian life sciences publication.
2011/03/16 14:40 - iSOFT Group Limited (ASX:ISF) said today that the group of seven NHS trusts in England, known as the iSOFT 7, will extend their agreements for patient and clinical management systems for five years, in deals totalling GBP12.6 million (A$20.2 million).
2011/03/16 14:29 - Two NHS trusts in Yorkshire have renewed contracts with iSOFT Group Limited (ASX:ISF) for patient administration systems (PAS) in deals that include new HP hardware and total GBP5.4 million.
2011/03/04 12:23 - Australian Market Report of March 4, 2011 includes: Winchester Resources Limited (ASX:WCR) further expand Belu Manganese Project in Indonesia; CBio Limited (ASX:CBZ) received "Chaperonin 10 Immunosuppression" patent from the Japanese Patent Office; Stellar Resources Limited (ASX:SRZ) announced high grade JORC resources at the Heemskirk Tin Project; NuPower Resources Limited (ASX:NUP) announced a resource estimate at Eva Tenement in the Westmoreland Project Areas.
Biotech